Target intelligence / Profile preview

Pattern recognition and antigen presentation pathways

Molecular classification
Receptor, Other
01

Overview

Pattern recognition and antigen presentation pathways represent the fundamental mechanisms by which the innate immune system detects threats and initiates adaptive immunity. Dendritic cells (DCs) and other professional antigen-presenting cells (APCs) utilize various Pattern Recognition Receptors (PRRs), including Toll-like receptors (TLRs), NOD-like receptors (NLRs), and C-type lectin receptors (CLRs), to sense pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) (Takeuchi & Akira, 2010, Cell). Following recognition, APCs undergo maturation, characterized by the upregulation of Major Histocompatibility Complex (MHC) molecules and co-stimulatory signals like CD80 and CD86 (Banchereau & Steinman, 1998, Nature). These pathways are essential for the processing of exogenous and endogenous antigens into peptides that are presented to T-cell receptors (TCRs), thereby orchestrating specific immune responses (Roche & Furuta, 2015, Nat Rev Immunol). In clinical practice, these pathways are targeted using PRR agonists as vaccine adjuvants or in cancer immunotherapy to overcome immune tolerance (Kaczanowska et al., 2013, Front Immunol). Conversely, overactivation of these pathways is a hallmark of many autoimmune and inflammatory diseases, making them significant areas of therapeutic research (Kawai & Akira, 2010, Nat Immunol).

Other names
Innate immune sensingAntigen processing and presentationPRR signaling pathwaysAPC activation pathways
02

Mechanism of action

Agonism of pattern recognition receptors (PRRs) to stimulate the maturation of dendritic cells and enhance the presentation of antigens to T cells.

03

Biological functions

Immune responseAntigen presentationSignal transductionCell activation
04

Disease associations

InfectionCancerInflammationAutoimmune disease
05

Safety considerations

Cytokine release syndromeSystemic inflammationInduction of autoimmunityInjection site reactions
06

Interacting drugs

Imiquimod

5 more in the full profile.

07

Biomarkers

CD80CD86HLA-DRInterleukin-12Interferon-alphaCD40

Beyond the preview

Go deeper on Pattern recognition and antigen presentation pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pattern recognition and antigen presentation pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call